6533b861fe1ef96bd12c5026
RESEARCH PRODUCT
Irradiation facility at the TRIGA Mainz for treatment of liver metastases
Jürgen Prof. Dr. KnorrHeinz SchmidbergerGerd OttoA. Lizon AguilarS. MinouchehrS. NagelsJens Volker KratzL. VogtländerB. WortmannC. SchützG. HampelMatthias Blaicknersubject
PhysicsModels StatisticalRadiationHuman liverbusiness.industryRadiotherapy Planning Computer-AssistedLiver NeoplasmsBoron Neutron Capture TherapyIn Vitro TechniquesTRIGAFast NeutronsNuclear ReactorsGermanyInternational congressHumansNuclear medicinebusinessMonte Carlo Methoddescription
Abstract The TRIGA Mark II reactor at the University of Mainz provides ideal conditions for duplicating BNCT treatment as performed in Pavia, Italy, in 2001 and 2003 [Pinelli, T., Zonta, A., Altieri, S., Barni, S., Braghieri, A., Pedroni, P., Bruschi, P., Chiari, P., Ferrari, C., Fossati, F., Nano, R., Ngnitejeu Tata, S., Prati, U., Ricevuti, G., Roveda, L., Zonta, C., 2002. TAOrMINA: from the first idea to the application to the human liver. In: Sauerwein et al. (Eds.), Research and Development in Neutron Capture Therapy. Proceedings of the 10th International Congress on Neutron Capture Therapy, Monduzzi editore, Bologna, pp. 1065–1072]. In order to determine the optimal parameters for the planned therapy and therefore for the design of the thermal column, calculations were conducted using the MCNP-code and the transport code ATTILA. The results of the parameter study as well as a possible configuration for the irradiation of the liver are presented.
| year | journal | country | edition | language |
|---|---|---|---|---|
| 2009-07-01 | Applied Radiation and Isotopes |